Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade GliomasÁlvaro Lassaletta, Bev Wilson, Marion Honnorat et al.|Journal of Clinical Oncology|2017Cited by 345
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responsesKatherine J. Brempelis, Courtney A. Crane|Journal for ImmunoTherapy of Cancer|2020Cited by 81